Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 2/2022

15.06.2021 | case report

Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report

verfasst von: MD Maher Salamoon, Mazen Kenj

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

The outbreak of coronavirus disease 2019 (COVID-19) has put health systems worldwide under great pressure on numerous levels. COVID-19 is a heterogeneous situation where some people experience mild symptoms for which no serious intervention is needed, while others may experience serious situations ranging from acute respiratory distress syndrome (ARDS) or even respiratory failure and end organ damage. Serious COVID-19 cases may be complicated with a cytokine storm caused by hemophagocytic lymphohistocytosis, which is a life-threatening situation. Efforts should be directed to reveal accompanying diseases that may trigger the cytokine storm. Early diagnosis leads to a better understanding of how to deal with this emergency status; however, even with early intervention, outcomes are still very poor.
Literatur
1.
Zurück zum Zitat Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061–1069. CrossRef Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061–1069. CrossRef
2.
Zurück zum Zitat Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16:82. CrossRef Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16:82. CrossRef
3.
Zurück zum Zitat Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49. CrossRef Al-Samkari H, Berliner N. Hemophagocytic Lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49. CrossRef
4.
Zurück zum Zitat Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033. CrossRef Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033. CrossRef
5.
Zurück zum Zitat Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805. CrossRef Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805. CrossRef
6.
Zurück zum Zitat Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic, lymphohistiocytosis. Br J Haematol. 2001;114:761. CrossRef Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic, lymphohistiocytosis. Br J Haematol. 2001;114:761. CrossRef
7.
Zurück zum Zitat Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90(3):220–4. CrossRef Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90(3):220–4. CrossRef
8.
Zurück zum Zitat Zhao Y, Lu D, Ma S, Li L, Zhu J, Zhou D et al. Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients. Hematology. 2019;24(1):606–12. CrossRef Zhao Y, Lu D, Ma S, Li L, Zhu J, Zhou D et al. Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients. Hematology. 2019;24(1):606–12. CrossRef
9.
Zurück zum Zitat Hayden A, Lin M, Park S, Pudek M, Schneider M, Jordan MB, et al. Soluble interleukin‑2 receptor is a sensitive diagnostic test in adult HLH. Blood Adv. 2017;1(26):2529–34. CrossRef Hayden A, Lin M, Park S, Pudek M, Schneider M, Jordan MB, et al. Soluble interleukin‑2 receptor is a sensitive diagnostic test in adult HLH. Blood Adv. 2017;1(26):2529–34. CrossRef
10.
Zurück zum Zitat Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H et al. Hematological features of persons with COVID‑19. Leukemia. 2020; 34(8):2163–2172. CrossRef Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H et al. Hematological features of persons with COVID‑19. Leukemia. 2020; 34(8):2163–2172. CrossRef
11.
Zurück zum Zitat La Rosée P, Horne A, Hines M, von Bahr GT, Machowicz R, Berliner N et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–77. CrossRef La Rosée P, Horne A, Hines M, von Bahr GT, Machowicz R, Berliner N et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–77. CrossRef
12.
Zurück zum Zitat Henter J‑I, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31. CrossRef Henter J‑I, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31. CrossRef
13.
Zurück zum Zitat Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int. 2016;58(9):817–25. CrossRef Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int. 2016;58(9):817–25. CrossRef
14.
Zurück zum Zitat Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613–20. CrossRef Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613–20. CrossRef
Metadaten
Titel
Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report
verfasst von
MD Maher Salamoon
Mazen Kenj
Publikationsdatum
15.06.2021
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2022
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00719-z